N
IMMX icon

Nuveen’s Immix Biopharma IMMX Stock Holding History

Nuveen’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
+102,979
New +$955K ﹤0.01% 2911

Other funds holding IMMX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen's IMMX Position: Q2 2026 in Review

Nuveen opened a new position in Immix Biopharma (IMMX) in Q2 2026: 102,979 shares worth $1.06M. The stake represents ﹤0.01% of the portfolio and ranks #2911 among its holdings.

59 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Nuveen held 102,979 shares of Immix Biopharma worth $1.06M as of Q2 2026.
  • Immix Biopharma was a new Nuveen position in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2911 holding.
  • 59 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.